These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15312979)

  • 1. Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages.
    Bender AT; Beavo JA
    Neurochem Int; 2004 Nov; 45(6):853-7. PubMed ID: 15312979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation.
    Shimizu-Albergine M; Rybalkin SD; Rybalkina IG; Feil R; Wolfsgruber W; Hofmann F; Beavo JA
    J Neurosci; 2003 Jul; 23(16):6452-9. PubMed ID: 12878685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J; Markerink-van Ittersum M; Vles JS
    J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain.
    Van Staveren WC; Steinbusch HW; Markerink-Van Ittersum M; Repaske DR; Goy MF; Kotera J; Omori K; Beavo JA; De Vente J
    J Comp Neurol; 2003 Dec; 467(4):566-80. PubMed ID: 14624489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterases in the central nervous system.
    Kleppisch T
    Handb Exp Pharmacol; 2009; (191):71-92. PubMed ID: 19089326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of human monocytes in vitro with granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor produces distinct changes in cGMP phosphodiesterase expression.
    Bender AT; Ostenson CL; Giordano D; Beavo JA
    Cell Signal; 2004 Mar; 16(3):365-74. PubMed ID: 14687666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
    Dunkern TR; Hatzelmann A
    Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains.
    Reyes-Irisarri E; Markerink-Van Ittersum M; Mengod G; de Vente J
    Eur J Neurosci; 2007 Jun; 25(11):3332-8. PubMed ID: 17553001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J; Grande JP
    Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular implications in the use of PDE5 inhibitor therapy.
    Maurice DH
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S20-3. PubMed ID: 15224131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile cavernosum.
    Lin CS; Lau A; Tu R; Lue TF
    Biochem Biophys Res Commun; 2000 Feb; 268(2):628-35. PubMed ID: 10679255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeled ligand binding to the catalytic or allosteric sites of PDE5 and PDE11.
    Weeks JL; Blount MA; Beasley A; Zoraghi R; Thomas MK; Sekhar KR; Corbin JD; Francis SH
    Methods Mol Biol; 2005; 307():239-62. PubMed ID: 15988068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterases 1 and 2 regulate cellular cGMP level in rabbit submandibular gland cells.
    Michikawa H; Sugiya H; Yoshigaki T; Fujita-Yoshigaki J; Furuyama S
    Int J Biochem Cell Biol; 2005 Apr; 37(4):876-86. PubMed ID: 15694846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic nucleotide specific phosphodiesterases of Leishmania major.
    Johner A; Kunz S; Linder M; Shakur Y; Seebeck T
    BMC Microbiol; 2006 Mar; 6():25. PubMed ID: 16522215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
    Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time monitoring of phosphodiesterase inhibition in intact cells.
    Herget S; Lohse MJ; Nikolaev VO
    Cell Signal; 2008 Aug; 20(8):1423-31. PubMed ID: 18467075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value?
    Albrecht K; Uckert S; Oelke M; Andersson KE; Jonas U; Tröger HD; Hedlund P
    J Forensic Leg Med; 2007 Jul; 14(5):270-4. PubMed ID: 17113813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity.
    Gupta R; Kumar G; Kumar RS
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):101-18. PubMed ID: 15834463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative feedback in NO/cGMP signalling.
    Koesling D; Mullershausen F; Lange A; Friebe A; Mergia E; Wagner C; Russwurm M
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1119-22. PubMed ID: 16246060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.